Lord, Abbett & Co. LLC Longboard Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.58 - $39.5 $4.55 Million - $6.51 Million	164,795 Added 35.66%	626,905 $20.9 Million
Q2 2024 Oct 07, 2024	SELL	$17.0 - $27.03 $222,173 - $353,255	-13,069 Reduced 2.75%	462,110 $12.5 Million
Q2 2024 Aug 14, 2024	SELL	$17.0 - $27.03 $222,173 - $353,255	-13,069 Reduced 2.75%	462,110 $12.5 Million
Q1 2024 Oct 07, 2024	BUY	$18.89 - $26.06 $246,873 - $340,578	13,069 Added 2.83%	475,179 $10.3 Million
Q1 2024 May 09, 2024	BUY	$18.89 - $26.06 $8.98 Million - $12.4 Million	475,179 New	475,179 $10.3 Million

3.7M

12.3K

13.9K

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $815M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.